Supriya Lifescience Limited stated that judicial proceedings involving its General Manager – Sales & Marketing remain sub judice. The company disclosed this update to stock exchanges on September 2, 2026.

The matter is currently awaiting hearing and adjudication before the Hon'ble Court of Law. No further development or order has been passed by the court as on date.

Regulatory Disclosure

This update references an earlier intimation dated July 4, 2026, submitted pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company had previously informed investors of the case status during its earnings call and through transcripts submitted to stock exchanges on August 14, 2026, and August 18, 2026, respectively.

Supriya Lifescience confirmed it will continue to monitor the matter. The company will inform the stock exchanges of any material development or court order as received, in accordance with applicable regulatory requirements.

Shareholders of Supriya Lifescience have approved the re-appointment of Mr. Balasaheb Sawant as Whole Time Director and Key Managerial Personnel for a term of three years.

The special resolution was passed with a requisite majority through remote e-voting conducted between July 23, 2026 and August 21, 2026. Mr. Sawant’s tenure will run from May 26, 2026 to May 25, 2029.

Voting Results

The company received votes from 361 shareholders representing 58,281,483 shares out of a total outstanding equity base of 80,482,800 shares as on the record date of July 17, 2026. This represents a participation rate of 72.41%.

Promoter group shareholders voted unanimously in favor, casting all 54,967,715 polled votes toward the resolution. Public institutional investors showed strong support with 94.38% of their polled votes in favor, while public non-institutional shareholders supported the resolution at 98.16%.

What the Numbers Show

The voting pattern highlights a clear divergence in engagement levels between promoter and public shareholders. While promoters achieved near-total participation (100% of held shares voted), public non-institutional shareholders participated at less than 1%, casting only 146,673 votes against their holding of over 16 million shares. Despite this low turnout from retail non-institutional holders, the overwhelming support from promoters and institutions ensured the resolution passed with 99.69% affirmative votes.